The first bellwether trial in the sprawling multidistrict opioid litigation began on May 3 in West Virginia federal court. The plaintiffs in the trial, Cabell County and the city of Huntington, West Virginia, which many consider the epicenter of the opioid drug...
Litigation Update: Opioid MDL Developments
In response to motions opposing additional bellwether trials filed on March 26 and March 29 by the nations’ biggest pharmacy chains, Judge Aaron Dan Polster issued an order rejecting the objections and reaffirming his plan to schedule an additional five trials in the...
Sacklers Balk at Chapter 11 Deal Without Litigation Injunction Extension
In a statement to the bankruptcy court on March 23, the family of Raymond Sackler advised that unless the injunction shielding the Sackler family from litigation was extended, they would withdraw their proposed $4.275 billion cash contribution to the settlement fund...
Litigation Update: Trove of Internal Documents to be Produced in Opioid Litigation
As part of a global resolution to the opioid litigation, pharmaceutical manufacturers and distributors have agreed to make public millions of pages of internal documents that detail the aggressive marketing and sales methods that fueled the epidemic. OxyContin...
Litigation Update: Purdue Pharma Pleads Guilty and Settles for $8.3 Billion
The DOJ has announced that Purdue Pharma, the maker of OxyContin, the opioid painkiller which had a big role in the U.S. opioid epidemic, has agreed to plead guilty to three federal criminal charges in addition to paying $8.3 billion. The agreement does not exonerate...
Litigation Update: Johnson & Johnson to Reach Deal to Settle 3,000 Opioid Cases
On Tuesday, October 13, J&J announced that it was increasing its settlement deal by $1 billion for a total of $5 billion in its efforts to put an end to almost 3,000 opioid lawsuits. This is part of the original $48 billion settlement framework proposed in 2019...
Litigation Update: Johnson & Johnson Fights Back Oklahoma’s Opioid Verdict
The Oklahoma court has ruled that it will allow organizations to file friend of the court briefs in support of J&J’s efforts to overturn a $465 million judgement for their role in contributing to the opioid epidemic in Oklahoma. The key issue in last week’s brief...
Litigation Update: Judge Defers Entry of Common Benefit Order Sought by Opioid MDL PEC
On July 27, the judge overseeing the National Prescription Opiate Multidistrict Litigation denied the Plaintiffs’ Executive Committee’s motion to establish a $3 billion common benefit fee fund, stating that the time was not right for a “one size fits all” common...
Litigation Update: Pharmacies Seek to Disqualify Federal Judge in Opioid MDL
On June 30, several major pharmacy chains, including CVS Health Corp., Walmart Inc., Rite-Aid Corp. and Walgreen Co. asked the Sixth Circuit to disqualify the judge overseeing the sprawling opioid litigation, Ohio U.S. District Judge Dan Aaron Polster, accusing him of...
Litigation Update: Pharmacies’ Petition to Overturn Untimely Dispensing Allegations Granted in the Opioid MDL
On April 15, the U.S. Court of Appeals for the Sixth Circuit unanimously granted the writ of mandamus filed by several major pharmacy chains, finding that U.S. District Judge Dan Polster of the Northern District of Ohio, who is presiding over the 2,600 case MDL,...